Next-generation Sequencing Library Preparation Market Size to Cross USD 6.44 Billion by 2034

The global next-generation sequencing (NGS) library preparation market size is projected to reach a valuation of USD 6.44 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.47% from USD 2.07 billion in 2025. This rapid growth is driven by technological advancements, increasing demand for high-throughput genomic analysis, and the expanding application scope in clinical diagnostics, personalized medicine, and pharmaceutical R&D.

The NGS library preparation market is witnessing a transformative phase, leveraging innovations in automation, microfluidics, and single-cell sequencing kits. Facilitated by the rising focus on precision medicine and disease genomics, the market’s growth is further fuelled by cost-effective sequencing solutions and expanding genomic research infrastructure across the globe.

North America remains the dominant region, accounting for 44% of market share in 2024, with Asia-Pacific emerging as the fastest-growing market at a CAGR of 15% during the forecast period.

Next-generation Sequencing Library Preparation Market Key Insights

• The market was valued at USD 2.07 billion in 2025 and is projected to surge to USD 6.44 billion by 2034.

• North America held the largest share in 2024, driven by advanced healthcare infrastructure and extensive research activities.

• Asia-Pacific is poised for rapid growth, supported by increasing investments in biotech and genomic research.

• Leading companies include Illumina, Thermo Fisher Scientific, Agilent Technologies, and QIAGEN, continuously innovating to meet rising demand.

• The market is predominantly served by manual/bench-top kits, though automated high-throughput systems are experiencing the fastest growth.

AI’s Role in Market Innovation

Artificial Intelligence (AI) is revolutionizing the NGS landscape by streamlining data analysis, enhancing accuracy, and reducing turnaround times. AI-driven algorithms enable faster interpretation of complex sequencing data, accelerating discoveries in clinical genomics and biomarker identification. AI-powered automation platforms are increasingly integrated into laboratory workflows, fostering high-throughput capacity and minimizing human error.

In addition, AI is instrumental in optimizing reagent design and customizing sequencing workflows, leading to reduced costs and improved reproducibility. These technological advances ensure that laboratories can process larger sample volumes efficiently, supporting personalized medicine initiatives and large-scale genomics projects.

Next-generation Sequencing Library Preparation Market Growth Factors and Opportunities

What are the key drivers fueling market expansion?
The primary factors include the surge in clinical research activities, the decreasing costs of sequencing, and technological advancements such as automation and microfluidics. Moreover, the growing adoption of NGS in infectious disease monitoring, oncology diagnostics, and pharmacogenomics is significantly propelling the industry’s growth.

Where do the biggest opportunities lie?
Innovative applications in single-cell genomics, liquid biopsy, and microbiome research are creating new revenue streams. The development of lyophilized and miniaturized kits, which reduce cold-chain dependencies, also presents lucrative opportunities for expanding reach, especially in emerging markets.

Next-generation Sequencing Library Preparation Market Scope

Industry Trends and Breakthroughs

Recent breakthroughs include Meridian Bioscience’s launch of lyophilized NGS library prep kits, eliminating refrigeration needs and streamlining logistics. Furthermore, NEB’s low-bias small RNA library kits exemplify the industry’s focus on tailored solutions for niche applications, broadening sequencing utility.

Leading companies are also investing heavily in automation, with systems that support high-throughput workflows, greatly reducing manual intervention. These advances facilitate large-scale genomics projects, biopharmaceutical R&D, and clinical diagnostic applications, aligning with the industry’s push towards faster, more accurate sequencing.

Challenges and Cost Pressures

Despite promising growth prospects, the market faces challenges related to the high cost of advanced automation systems and reagent consumables. Regulatory hurdles and the need for extensive validation in clinical settings further complicate market expansion, especially for new entrants. Additionally, demand for cost-effective, scalable solutions remains a critical pressure point, influencing ongoing innovation.

Next-generation Sequencing Library Preparation Market Regional Analysis

North America continues to dominate the market, leveraging its sophisticated research infrastructure, significant government funding, and early adoption of cutting-edge innovations.

The U.S. alone is projected to reach over USD 2.16 billion by 2034, driven by strong industry presence and extensive R&D investments.

Asia-Pacific, with its rapidly growing healthcare systems and increasing biotech investments, is emerging as the fastest-growing regional market. Countries like China and India are fostering a vibrant ecosystem of startups and established players, expanding the adoption of advanced sequencing technologies.

Next-generation Sequencing Library Preparation Market Segmentation Analysis

Product Type Insights

Library Preparation Kits Lead the Market

In 2024, the library preparation kits segment dominated the global next-generation sequencing (NGS) library preparation market, capturing a 50% market share. This dominance is attributed to their essential role in creating high-quality DNA and RNA libraries for sequencing. Their versatility, ease of integration, and widespread adoption across clinical, pharmaceutical, and research laboratories make them indispensable in genomics workflows.

Automation & Instruments Growing Rapidly

The automation and library prep instruments segment is expected to record the fastest CAGR of 13% during the forecast period. The growth is driven by laboratories adopting automated, high-throughput sequencing solutions to reduce manual errors and enhance reproducibility. These systems enable efficient large-scale genomic studies, supporting the growing demand for faster and more reliable sequencing outputs.

Technology / Sequencing Platform Compatibility Insights

Illumina Platforms Hold the Largest Share

The Illumina platforms segment led the market in 2024 with a 45% share, primarily due to their broad compatibility with multiple library preparation kits and their proven accuracy and scalability. Their dominance is reinforced by a large global user base, strong technical support, and consistent performance across both clinical and research applications.

Oxford Nanopore Technologies Rising Fast

The Oxford Nanopore Technologies (ONT) platforms segment is projected to grow at the fastest CAGR of 14% during the forecast period. ONT’s real-time data generation, portable sequencing systems, and long-read sequencing capabilities cater to the rising demand for rapid diagnostics and comprehensive genome analysis, particularly in emerging markets and field-based research projects.

Application Insights

Clinical Research Segment Dominates

The clinical research segment held a 40% market share in 2024, driven by increasing demand for precision medicine, biomarker discovery, and genetic disease studies. The adoption of NGS in patient stratification, diagnostic validation, and translational research underscores its growing relevance in clinical genomics.

Pharmaceutical & Biotech R&D Expanding Fast

The pharmaceutical and biotechnology R&D segment is forecasted to grow at a 13.5% CAGR, fueled by the integration of NGS library preparation in drug discovery, clinical trials, and personalized therapies. As genomic and transcriptomic research deepens, NGS-based library preparation has become central to pharma-driven innovation and therapeutic development.

End User Insights

Hospitals & Clinical Laboratories Lead

In 2024, hospitals and clinical laboratories dominated the NGS library preparation market with a 42% market share. The increasing application of NGS in infectious disease diagnostics, oncology testing, and personalized medicine drives this leadership. The segment benefits from the need for highly accurate, reproducible, and timely diagnostic results in clinical environments.

Pharmaceutical Companies to Grow Fastest

The pharmaceutical companies segment is projected to grow at a CAGR of 13% during the forecast period. Rising R&D investments, genomics-based drug development, and the adoption of automated library preparation technologies are key factors driving this segment’s rapid expansion.

Library Preparation Type Insights

Manual / Bench-Top Preparation Dominates

The manual or bench-top preparation segment captured a 55% market share in 2024, maintaining its dominance due to cost-effectiveness, flexibility, and customization. Despite the shift toward automation, manual methods remain vital in academic and small-scale research laboratories for tailored and specialized genomic studies.

Automated / High-Throughput Preparation Gaining Momentum

The automated and high-throughput preparation segment is set to grow at the fastest rate over the coming years. The surge in standardized laboratory workflows, scalability needs, and reduced human error continues to drive adoption. These systems are increasingly integral to large-scale genomics projects and industrial R&D applications.

Top Companies Driving Innovation

• Illumina: Pioneering high-accuracy, automation-compatible library prep kits like Nextera and TruSeq.

• Thermo Fisher Scientific: Offering scalable solutions across DNA, RNA, and epigenetic workflows.

• Agilent Technologies: Focusing on customizable and precise targeted sequencing kits.

• QIAGEN: Known for its robust, reproducible liquid biopsy and clinical research kits.

• 10x Genomics: Specializing in single-cell and spatial genomics solutions, enabling cellular-resolution insights.

Segments Covered in the Report

By Product Type

• Library Preparation Kits
  • DNA Library Preparation Kits
    • Whole Genome Sequencing (WGS) Kits
    • Targeted Sequencing Kit
    •  Exome Sequencing Kits
• RNA Library Preparation Kit
  • • mRNA Sequencing Kits
    • Total RNA / rRNA Depletion Kits
    • Small RNA / miRNA Sequencing Kits
  • Single-Cell Library Preparation Kits
  • Other Specialized Kits (ChIP-Seq, Methylation Kits, etc.)
• Library Preparation Reagents & Consumables
  • Enzymes (Reverse Transcriptase, DNA Polymerase, Ligases, etc.)
  • Adapters & Indexes
  • Buffers & Reaction Mixes
  • Purification & Cleanup Kits
• Automation & Library Prep Instruments (Optional)
  • Robotic Liquid Handling Systems
  • Microfluidics-Based Platforms

By Technology / Sequencing Platform Compatibility

• Illumina Platforms
• Thermo Fisher / Ion Torrent Platforms
• Pacific Biosciences (PacBio) Platforms
• Oxford Nanopore Technologies Platforms
• Other Sequencing Platforms

By Application

• Clinical Research
  • Genetic Disorders & Rare Disease Research
  • Cancer Genomics
  • Infectious Disease / Pathogen Detection
• Pharmaceutical & Biotech R&D
  • Drug Discovery & Development
  • Personalized Medicine Research
• Academic & Basic Research
  • Functional Genomics
  • Transcriptomics & Epigenomics
• Agrigenomics & Plant/Animal Research
• Other Applications
  • Microbiome Analysis
  • Metagenomics
  • Environmental & Industrial Research

By End User

• Hospitals & Clinical Laboratories
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Government & Public Health Laboratories

By Library Preparation Type

• Manual / Bench-top Preparation
• Automated / High-Throughput Preparation

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Read Also: SGLT-2 Inhibitors Market